The purpose of the Framework Agreement is the supply of proprietary medicinal products, and more specifically Abiraterone, Trabectedin, Cabazitaxel, Fulvestrant, Rituximab IV in the form of 5 Lots
AbiratéroneSupply of Abiraterone
TrabectédineSupply of Trabectedin
CabazitaxelSupply of Cabazitaxel
FulvestrantSupply of Fulvestrant
Rituximab IVFourniture de Rituximab IV